Supreme Court Denies Sequenom’s Petition for Certiorari

By Ron Kern on July 13, 2016 Posted in Uncategorized

On June 27, 2016, the U.S. Supreme Court, without comment, denied Sequenom’s petition for certiorari, leaving in place the Court’s previous rulings prohibiting the patenting of laws of nature and natural phenomenon. Read more >>… Continue Reading

Supreme Court Asked to Clarify Limits on Diagnostic Method Patents

By Ron Kern on April 18, 2016 Posted in Uncategorized

Arguing that the current state of the law weakens the patent system and poses a danger to life science innovators, biotechnology company, Sequenom, Inc., has filed a writ of certiorari with the U.S. Supreme Court, asking the Court to provide clarification regarding the limits of 35 U.S.C. § 101 as it relates to patent eligibility of diagnostic … Continue Reading

Australian High Court Rules Gene Patents Unpatentable

By Maurice Valla on October 28, 2015 Posted in Uncategorized

Decision reverses decades of precedent and calls into question the validity of literally thousands of issued Australian patents Like the U.S. Supreme Court, the High Court of Australia has determined that Myriad’s patents directed to purified and isolated DNA molecules encoding the BRCA genes are unpatentable. Indeed, the High Court of Australia went one step … Continue Reading